Case-mix-adjusted mean number of polyps per 100 procedures: a new candidate gold standard colonoscopy key performance indicator [0.03%]
经病例组合调整的每百例操作平均腺瘤数量：新的结肠镜检查关键绩效指标候选“金标准”
Jamie Catlow,Liya Lu,Linda Sharp et al.
Jamie Catlow et al.
Objective: Adenoma detection rate (ADR) has been criticised as a colonoscopy key performance indicator (KPI), for excluding serrated polyps, requiring histological data and fostering a 'one-and-done' attitude. We hypothes...
Italian Chronic Pancreatitis Registry (ITARECIPE): protocol for a nationwide cohort study [0.03%]
意大利慢性胰腺炎注册登记（ITARECIPE）：全国队列研究方案
Giacomo Emanuele Maria Rizzo,Laura Apadula,Matteo Piciucchi et al.
Giacomo Emanuele Maria Rizzo et al.
Introduction: Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas leading to permanent damage, resulting in both exocrine and endocrine insufficiency. Understanding the management of patients w...
Impact of digital health interventions on patient satisfaction in outpatient gastrointestinal endoscopy: a systematic review [0.03%]
数字健康干预对门诊消化内镜患者满意度的影响：系统性回顾研究
Seán Fennessy,Caoimhe McGarvey,Edel McDermott et al.
Seán Fennessy et al.
Objectives: The integration of digital health technologies in gastrointestinal (GI) endoscopy presents opportunities to enhance patient experience, an important dimension of care quality. This systematic review aims to ev...
Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective [0.03%]
质子泵抑制剂与胃癌风险的系统评价、证据综合及生命历程流行病学视角
Nele Brusselaers,Habiba Khodir Kamal,David Graham et al.
Nele Brusselaers et al.
Objectives: Since proton pump inhibitors (PPI) have been introduced, many concerns were raised regarding potential gastric carcinogenicity. We aim to summarise and weigh the epidemiological evidence and address possible c...
eHealth interventions and patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis [0.03%]
代谢紊乱相关脂肪性肝病患者的电子健康干预措施：系统评价和meta分析
Yousuf Zafar,Muhammad Umer Sohail,Muhammad Saad et al.
Yousuf Zafar et al.
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, with increasing mortality rates driven by the obesity pandemic. Weight loss has been shown to improve MASLD o...
Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy - a retrospective cohort study [0.03%]
比较不同减肥疗法后胃轻瘫的风险：司美格鲁肽 vs 安非他酮-纳曲酮 vs 胃袖状切除术——一项回顾性队列研究
Chino Aneke-Nash,Kay Su Hung,Elizabeth Wall-Wieler et al.
Chino Aneke-Nash et al.
Objective: The use of glucagon-like peptide 1 receptor agonists has been associated with gastroparesis, but little is known about the risk of gastroparesis in those with obesity but without type 2 diabetes (T2D), and how ...
Comparative Study
BMJ open gastroenterology. 2025 Apr 2;12(1):e001704. DOI:10.1136/bmjgast-2024-001704 2025
Derivation and validation of lifestyle-based and microbiota-based models for colorectal adenoma risk evaluation and self-prediction [0.03%]
基于生活方式和微生物组的结直肠腺瘤风险评估和自我预测模型的推导与验证
Yi-Lu Zhou,Jia-Wen Deng,Zhu-Hui Liu et al.
Yi-Lu Zhou et al.
Objective: Early warning and screening of colorectal adenoma (CRA) is important for colorectal cancer (CRC) prevention. This study aimed to construct a non-invasive prediction model to improve CRA screening efficacy. ...
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial [0.03%]
对于接受先进疗法且症状缓解的炎症性肠病患者，实现内镜下缓解的治疗方法（QUOTIENT）：一项开放标签、多中心、实用随机对照试验的原理、设计和方案
Siddharth Singh,Jasmine D Nguyen,David I Fudman et al.
Siddharth Singh et al.
Introduction: Targeted immunomodulators (eg, advanced therapies) effectively achieve symptomatic remission in patients with inflammatory bowel disease (IBD). However, ~25%-50% of patients with IBD achieving symptomatic re...
Multicenter Study
BMJ open gastroenterology. 2025 Mar 31;12(1):e001615. DOI:10.1136/bmjgast-2024-001615 2025
What is the optimal first-line treatment of autoimmune hepatitis? A systematic review with meta-analysis of randomised trials and comparative cohort studies [0.03%]
自身免疫性肝炎的一线治疗是什么？带有随机试验和比较队列研究的系统评价及荟萃分析
Dermot Gleeson,Marrissa Martyn-StJames,Ye Oo et al.
Dermot Gleeson et al.
Objectives: Uncertainty remains about many aspects of first-line treatment of autoimmune hepatitis (AIH). Design: Systemic review with ...
Post-colonoscopy colorectal cancer and the association with endoscopic findings in the Danish colorectal cancer screening programme [0.03%]
结肠镜检查后发生结直肠癌以及丹麦结直肠癌筛查项目中的内镜发现的关联性研究
Simon Ladefoged Rasmussen,Lasse Pedersen,Christian Torp-Pedersen et al.
Simon Ladefoged Rasmussen et al.
Objective: Colorectal cancer (CRC) is the third most common cancer in Denmark, with a 5-year mortality of 40%. To reduce CRC incidence and mortality, a faecal immunochemical test (FIT)-based screening programme was introd...